Onconova Therapeutics, a biotech focused on developing drug candidates for cancer and related diseases, raised $78 million by offering 5.2 million shares at $15, above the range of $12 to $14. The Newtown, PA-based company had originally planned to offer 4.6 million shares. Onconova Therapeutics, which now has a market cap of approximately $310 million, will list on the NASDAQ under the symbol ONTX. Citi and Leerink Swann acted as lead managers on the deal.
